Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02257151 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects
A Phase 1 study of Healthy Adult, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT02257151 is a Phase 1 study of Healthy Adult that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 118 participants, above the 59-participant average among 8 other Healthy Adult trials with a reported enrollment target (100% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02257151, a Phase 1 study of Healthy Adult, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and target engagement of BMS-986142 in healthy subjects.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG BMS-986142
Study Locations (1)
California
- Wcct Global, Llc - Cypress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02257151
The ClinicalTrials.gov registry entry for NCT02257151 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 59-participant average among 8 other Healthy Adult trials with a reported enrollment target (100% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Adult appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02257151 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02257151 about?
NCT02257151 is a clinical study titled "Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects". The purpose of this study is to evaluate the safety, pharmacokinetics, and target engagement of BMS-986142 in healthy subjects.
What is the current status of trial NCT02257151?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2014-09. Estimated completion is 2015-08.
What conditions does trial NCT02257151 study?
This clinical trial studies the following conditions: Healthy Adult.
What interventions are being tested in trial NCT02257151?
The interventions under investigation include: Placebo (DRUG), BMS-986142 (DRUG).
Who is sponsoring clinical trial NCT02257151?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02257151 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Skin Irritation and Sensitization of SILURCLOUD Fibrous Collagen Matrix
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Skin Prick Test to Evaluate Immunogenic Response of SILURCLOUD™ Fibrous Collagen Matrix in Healthy Volunteers
RECRUITING · NA
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
RECRUITING · NA
-
Molecular Indicators of Systematic Fitness
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.